Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection - Wikidata - awgldk - TriplyDB

Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection

Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection

http://www.wikidata.org/entity/Q33516015

about

Staphylococcal response to oxidative stress Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model Alternative antimicrobial approach: nano-antimicrobial materials Topical antimicrobials for burn infections - an update Pterostilbene, a Methoxylated Resveratrol Derivative, Efficiently Eradicates Planktonic, Biofilm, and Intracellular MRSA by Topical Application.Metabolite cross-feeding enhances virulence in a model polymicrobial infection.Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications.Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response Nanomedicine in the Management of Microbial Infection - Overview and Perspectives Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus.Fidgetin-Like 2: A Microtubule-Based Regulator of Wound Healing Focal Infection Treatment using Laser-Mediated Heating of Injectable Silk Hydrogels with Gold Nanoparticles.Nanocarriers for nitric oxide delivery.Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent.Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses.Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infections.Methamphetamine Alters the Antimicrobial Efficacy of Phagocytic Cells during Methicillin-Resistant Staphylococcus aureus Skin Infection.Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model In vivo pharmacological activity and biodistribution of S-nitrosophytochelatins after intravenous and intranasal administration in mice.Nitric oxide therapy for dermatologic disease.Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.The potential of nitric oxide releasing therapies as antimicrobial agents.Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections.Antimicrobial activity of topically-applied soyaethyl morpholinium ethosulfate micelles against Staphylococcus species.Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.Nitric oxide generating/releasing materials.Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance.Antibiotic-Releasing Silk Biomaterials for Infection Prevention and Treatment.Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.Inhibition of methicillin resistant Staphylococcus aureus by a plasma needle

P2860

Q26991866-EBDAA1AF-2462-4D83-947B-42CDCDAC19DB Q27001203-5D4DFC5B-A631-425C-862B-4B753F1F9031 Q27325703-21DD0D83-A661-4B6D-ABF5-9EC5E296D3F7 Q28081490-224F41BC-850D-4FBA-A2C2-01356E303885 Q33600002-34D7E5DB-72F7-413A-8483-B0B9A5798389 Q33790112-50197921-BE2F-4D05-B8D4-33DEFA34DC18 Q33869479-40AF4D11-F6E5-48C4-AC55-041B5E4F40B3 Q33951477-D925C0AF-58DE-4AE6-A1BE-D274168A7828 Q34066198-82086F66-D029-44E5-B4DE-728B25FB3614 Q34141284-E31A7868-3946-4EC1-B7AA-DED0B6ACBDAE Q34245494-513DB4F4-0113-4089-B791-D2F97AB0F84E Q34385696-C1668B63-4C3A-43A0-AFEB-3F98B4B383DF Q34466491-F232B78B-5F08-4293-BCDA-D08D697165D2 Q34981229-3361E7C6-BCF3-4E16-BCDE-F200BA7FD0FF Q35176430-D0D19039-3119-4AFB-9B98-E2467A6A7BE8 Q35705744-D32918CB-B33A-48AE-8BB5-F73B0B04DB4C Q35914150-C254D099-0391-4270-B800-18F8FE39970E Q36018405-7FB96CFE-00F0-45F9-97DD-1B73920496F2 Q36227306-76B3DE58-FE4A-482C-B08E-4BF7EDDA066D Q36730043-2977A39C-0F29-487A-AF1C-35282F90D813 Q37302973-CADF4AAC-54F3-4D4A-93A0-7B17E8A436EF Q37474339-EBA71CC1-7072-47F5-9999-13A3A5C4CF32 Q37538654-641886CA-55C4-43CB-871C-E1BCC66E7A80 Q38006608-480D5223-FA87-4CC8-AAF1-CCAF8602C1C9 Q38105519-72BC7926-5071-4698-9EA0-579D1129AD49 Q38791359-9D607A63-6308-41C6-9AD2-A10CC4F522D1 Q38884364-EADC40DD-4891-4273-A57F-8E82C244AFAD Q38910851-0FBE6925-C860-4A41-9E38-6355EAA30CD8 Q39515768-A44D3205-102F-44B2-8418-56FC99F66F37 Q41553971-1C0B2A83-C1E0-47F1-A440-9C701A4B27E9 Q45915137-84372A70-7799-458F-AA60-7BB2862E0AD0 Q58726245-2976E1AD-3281-496E-AC2C-8262957637BD

P2860

Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection

http://www.wikidata.org/entity/Q33516015

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Nitric oxide releasing nanopar ...... in a murine model of infection

@ast

Nitric oxide releasing nanopar ...... in a murine model of infection

@en

Nitric oxide releasing nanopar ...... n a murine model of infection.

@nl

type

label

Nitric oxide releasing nanopar ...... in a murine model of infection

@ast

Nitric oxide releasing nanopar ...... in a murine model of infection

@en

Nitric oxide releasing nanopar ...... n a murine model of infection.

@nl

prefLabel

Nitric oxide releasing nanopar ...... in a murine model of infection

@ast

Nitric oxide releasing nanopar ...... in a murine model of infection

@en

Nitric oxide releasing nanopar ...... n a murine model of infection.

@nl

P1433

Q33516015-C81B899B-6C01-468D-A078-475999D6F7E5

P1476

Q33516015-684AD842-4F93-49CA-A0EC-8E5090E11B8F

P2093

Q33516015-0B595668-E369-4CA8-9384-3E1D90B461A3

Q33516015-5ECB4E36-0325-43C1-A5F9-FC947FA56127

Q33516015-5FE4F44E-09D3-4254-9636-C1369EACDCD6

Q33516015-68EE86E5-B45C-4EC0-B33A-7D3D3BB98315

Q33516015-E1558A71-5A88-472D-B85E-F75B705F462F

P2860

Q33516015-00506D44-CC00-4ECE-9BEB-833FBA78DDED

Q33516015-0606DD1D-EECD-4919-9309-67B37BC225A3

Q33516015-08AAFC91-92B4-45AE-BEAE-6DED3455D0D1

Q33516015-142817A6-E08E-4F7A-91BA-0A24677856F3

Q33516015-2342A29A-0491-450C-94BC-F5FC94DD236D

Q33516015-274CEE37-EF7E-4AE6-9205-E35AA6C0E8B7

Q33516015-2C317F4D-C313-43E9-97FF-4D6298BD7389

Q33516015-45BF9F6A-7881-4D10-927E-5B0CE6A1E942

Q33516015-477D8EC5-11F1-4D77-9C67-01F45E47FCEE

Q33516015-4ADB3B06-331C-4864-9246-01D4E87D26DC

P304

Q33516015-B8BBF436-099A-45DF-B846-758BBE860CFF

P31

Q33516015-D3ACC3FB-3E50-412D-888E-FB0C6490DC38

P356

Q33516015-5F5D0A9A-D8EA-4713-B01D-E40218EC9DF1

P407

Q33516015-EDA3A4F5-F902-4D74-BEB8-B66FBCA21EAC

P433

Q33516015-57FAC117-886D-4F3F-B026-0E948390CABA

P478

Q33516015-DF085129-6606-474B-B30D-C03421F3D59C

P50

Q33516015-5938D7B9-E4BE-4A7D-B62C-2EA457636874

P577

Q33516015-852F70B0-52CC-4299-A894-F2217F889C51

P5875

Q33516015-0AB20C1A-5BDD-4640-8347-097B9F68307C

P698

Q33516015-1075A550-9FD8-4C08-B09D-26268213F87F

P921

Q33516015-D6047159-4544-45D4-8B85-E3C3930485C7

P932

Q33516015-BCD8B05E-A1DC-46D8-9316-B47E4659CD84

P356

JOURNAL.PONE.0007804

P1433

P1476

Nitric oxide releasing nanopar ...... in a murine model of infection

@en

P2093

George Han

http://www.w3.org/2001/XMLSchema#string

Joel M Friedman

http://www.w3.org/2001/XMLSchema#string

Joshua D Nosanchuk

http://www.w3.org/2001/XMLSchema#string

Luis R Martinez

http://www.w3.org/2001/XMLSchema#string

Mircea Radu Mihu

http://www.w3.org/2001/XMLSchema#string

P2860

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Nitric oxide drives skin repair: novel functions of an established mediator.

Chitosan as antimicrobial agent: applications and mode of action.

Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care

Role of nitric oxide, nitroxidative and oxidative stress in wound healing.

A pilot study on acute inflammation and cancer: a new balance between IFN-gamma and TGF-beta in melanoma.

Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer

Wound healing alterations caused by infection.

Unraveling the biological significance of nitric oxide.

P304

e7804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0007804

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Adam J. Friedman

P577

2009-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38091577

http://www.w3.org/2001/XMLSchema#string

P698

19915659

http://www.w3.org/2001/XMLSchema#string

P921

P932

2771897

http://www.w3.org/2001/XMLSchema#string